Mirae Asset Global Etfs Holdings Ltd. Applied Therapeutics Inc. Transaction History
Mirae Asset Global Etfs Holdings Ltd.
- $43.9 Billion
- Q4 2024
A detailed history of Mirae Asset Global Etfs Holdings Ltd. transactions in Applied Therapeutics Inc. stock. As of the latest transaction made, Mirae Asset Global Etfs Holdings Ltd. holds 55,108 shares of APLT stock, worth $25,900. This represents 0.0% of its overall portfolio holdings.
Number of Shares
55,108
Previous 59,022
6.63%
Holding current value
$25,900
Previous $501,000
90.82%
% of portfolio
0.0%
Previous 0.0%
Shares
2 transactions
Others Institutions Holding APLT
# of Institutions
130Shares Held
112MCall Options Held
1.1MPut Options Held
800K-
Vestal Point Capital, LP New York, NY11.5MShares$5.41 Million0.58% of portfolio
-
Vr Adviser, LLC New York, NY9.99MShares$4.7 Million1.4% of portfolio
-
Propel Bio Management, LLC Los Angeles, CA9.62MShares$4.52 Million8.18% of portfolio
-
Morgan Stanley New York, NY8.82MShares$4.14 Million0.0% of portfolio
-
Schonfeld Strategic Advisors LLC New York, NY8.76MShares$4.12 Million0.05% of portfolio
About Applied Therapeutics Inc.
- Ticker APLT
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 48,020,700
- Market Cap $22.6M
- Description
- Applied Therapeutics, Inc., a clinical-stage biopharmaceutical company, develops novel products to target cardiovascular disease, galactosemia, and diabetic complications. Its lead product candidate is AT-007 that has completed phase 1/2 for the treatment of galactosemia in healthy volunteers and adults, as well as is in pediatric clinical study...